No Data
No Data
Iovance Biotherapeutics Is Maintained at Market Outperform by JMP Securities
Iovance Biotherapeutics Is Maintained at Market Outperform by JMP Securities
JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating
Iovance Biotherapeutics (IOVA) has an average buy rating and a price target range of $19 to $34, according to analysts polled by Capital IQ.
JMP Securities Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Cuts Target Price to $23
JMP Securities analyst Reni Benjamin maintains $Iovance Biotherapeutics(IOVA.US)$ with a buy rating, and adjusts the target price from $25 to $23.According to TipRanks data, the analyst has a success
Bullish Iovance Biotherapeutics Insiders Loaded Up On US$74.9m Of Stock
Quite a few insiders have dramatically grown their holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) over the past 12 months. An insider's optimism about the company's prospects is a positive si
M&A Is Back. 4 Stocks That Could Be Targets.
Mergers and acquisitions are on pace for a solid year. Small-cap biotech and tech look interesting.
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why